Cheers Mozz, I guess everyone has their price. Being a private company also helps fend off T/Os. My thinking is a large pharma would want to control everything from manufacturing to distribution. If this is the case where would they start first?
Ann: Paradigm and Bene Execute New Collaboration Agreement, page-39
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
25.5¢ |
Change
0.005(2.00%) |
Mkt cap ! $89.19M | |||
| Open | High | Low | Value | Volume |
| 25.0¢ | 25.5¢ | 23.5¢ | $105.4K | 437.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1325 | 24.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.5¢ | 29564 | 3 |
View Market Depth
| Last trade - 16.10pm 29/08/2024 (20 minute delay) ? |
| PAR (ASX) Chart |